Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Iznardo

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Chronic Disease|August 19, 2021
Dual inhibition of IL-17A and IL-17F in psoriatic diseaseHelena Iznardo, Lluís Puig
Expert Review of Clinical Immunology|February 4, 2021
The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectivesHelena Iznardo, Lluís Puig
Current Opinion in Rheumatology|June 14, 2022
Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypesHelena Iznardo, Lluís Puig
Expert Opinion on Drug Safety|February 14, 2020
The safety of brodalumab for the treatment of psoriasisHelena Iznardo, Lluís Puig
International Journal of Molecular Sciences|August 26, 2022
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic ImplicationsHelena Iznardo, Luís Puig
International Journal of Molecular Sciences|April 30, 2021
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic DiseaseHelena Iznardo, Lluís Puig
Clinical, Cosmetic and Investigational Dermatology|November 23, 2020
Lentigo Maligna: Clinical Presentation and Appropriate ManagementHelena Iznardo, Cristina Garcia-Melendo, Oriol Yélamos
Pediatric Neurology|August 27, 2023
Sclerotic Bone Lesions as a Clue in the Diagnosis of Three Generations of Tuberous Sclerosis Complex: Case Report and Review of LiteratureHelena Iznardo, Sara Bernal, Susana Boronat, et al.
Pharmaceutics|February 25, 2023
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic DermatitisHelena Iznardo, Esther Roé, Esther Serra-Baldrich, et al.
Pediatric Dermatology|April 24, 2020
Propranolol-resistant infantile hemangioma successfully treated with sirolimusVictoria L Dávila-Osorio, Helena Iznardo, Esther Roé, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Chronic Disease|August 19, 2021
Dual inhibition of IL-17A and IL-17F in psoriatic diseaseHelena Iznardo, Lluís Puig
Expert Review of Clinical Immunology|February 4, 2021
The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectivesHelena Iznardo, Lluís Puig
Current Opinion in Rheumatology|June 14, 2022
Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypesHelena Iznardo, Lluís Puig
Expert Opinion on Drug Safety|February 14, 2020
The safety of brodalumab for the treatment of psoriasisHelena Iznardo, Lluís Puig
International Journal of Molecular Sciences|August 26, 2022
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic ImplicationsHelena Iznardo, Luís Puig
International Journal of Molecular Sciences|April 30, 2021
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic DiseaseHelena Iznardo, Lluís Puig
Clinical, Cosmetic and Investigational Dermatology|November 23, 2020
Lentigo Maligna: Clinical Presentation and Appropriate ManagementHelena Iznardo, Cristina Garcia-Melendo, Oriol Yélamos
Pediatric Neurology|August 27, 2023
Sclerotic Bone Lesions as a Clue in the Diagnosis of Three Generations of Tuberous Sclerosis Complex: Case Report and Review of LiteratureHelena Iznardo, Sara Bernal, Susana Boronat, et al.
Pharmaceutics|February 25, 2023
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic DermatitisHelena Iznardo, Esther Roé, Esther Serra-Baldrich, et al.
Pediatric Dermatology|April 24, 2020
Propranolol-resistant infantile hemangioma successfully treated with sirolimusVictoria L Dávila-Osorio, Helena Iznardo, Esther Roé, et al.
Pageof 3